Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Switzerland
  4. Swiss Exchange
  5. COLTENE Holding AG
  6. News
  7. Summary
    CLTN   CH0025343259

COLTENE HOLDING AG

(CLTN)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

EQS-Adhoc : Investor Day - positive sales and earnings performance in the first half of the year

06/23/2021 | 01:03am EDT
EQS Group-Ad-hoc: COLTENE Holding AG / Key word(s): Miscellaneous 
Investor Day - positive sales and earnings performance in the first half of the year 
23-Jun-2021 / 07:00 CET/CEST 
Release of an ad hoc announcement pursuant to Art. 53 LR 
The issuer is solely responsible for the content of this announcement. 
=---------------------------------------------------------------------------------------------------------------------- 
COLTENE Holding AG is holding an analyst and investor meeting at its headquarters in Altstätten today and provides a 
trading update on the first half of 2021. The positive performance previously announced for the first quarter has 
continued, with sales and earnings both running ahead of expectations this year. However, the company is expecting a 
slightly slower rate of growth in the second half of the year, as the catch-up and recovery effects from the 
coronavirus pandemic fade over time. 
COLTENE expecting an excellent result for the first half of the year 
The COLTENE Group's sales performance remained strong in the second quarter. The company benefited from the easing of 
COVID-19 restrictions in its core markets and the resultant increase in dental treatments in many markets. 
The dental group expects sales to be up significantly in the first six months of this year on the same period last year 
and also higher than the pre-pandemic level in the first half of 2019, although there is a negative exchange rate 
effect of 6% compared with 2019. The cost-cutting measures put in place during the pandemic last year have led to a 
lower cost base, which coupled with higher sales is now feeding through to the bottom line. COLTENE's management 
believes that the strong sales performance so far this year has partly been driven by catch-up effects. Many dental 
vendors took advantage of the coronavirus pandemic to temporarily reduce their inventories. Therefore, sales in the 
first half of the year cannot be extrapolated. 
COLTENE's management anticipates sales of between CHF 140 million and CHF 145 million in the first half of the year (H1 
/2020: CHF 103.9 million; H1/2019: CHF 135.4 million), with sales slightly weaker in the second half of 2021 compared 
to the first half of the year. Sales are projected at between CHF 270 and CHF 280 million for the full year (previous 
year: CHF 248.4 million; 2019: CHF 273.8 million). This would represent an organic growth of around 5 to 8% in sales 
compared with 2019 in currency-adjusted terms. On these assumptions the EBIT margin is forecast to reach over 15% for 
the full year 2021. Certain costs, e.g. marketing and sales, will be higher this year. On top of this the outlook for 
the full year 2021 continues to involve risks and uncertainties relating to the COVID-19 pandemic. Detailed information 
on the company's financial performance will be published in the half-year report on August 6, 2021. 
Financial calender 
Release of Half-year Report 2021 and                 August 6, 2021 
Conference call on the half-year results 2021 
Release of Annual Report 2021 and                    March 4, 2022 
Media and analyst conference on 2021 financial year 
Annual General Meeting 2022                          April 21, 2022 
Release of Half-year Report 2022 and                 August 5, 2022 
Conference call on the half-year results 2022 

Sign up for email updates from COLTENE Holding AG at www.coltene.com.

For further information: Gerhard Mahrle, CFO, phone +41 71 757 54 37, mobile +41 79 346 23 02, e-mail gerhard.mahrle@coltene.com

About COLTENE COLTENE is an internationally active developer, manufacturer and seller of dental consumables and small equipment in the areas of Infection Control, Dental Preservation and Efficient Treatment. COLTENE has state-of-the-art production facilities in the USA, Canada, Germany, France, Brazil and Switzerland as well as own distribution organizations in all major markets including Europe, North and Latin America, China and India. Dentists and dental labs all around the globe trust COLTENE's high-quality products. The registered shares of COLTENE Holding AG (CLTN) are listed on SIX Swiss Exchange. Learn more about COLTENE and our products at www.coltene.com.

Contact information COLTENE Holding AG Feldwiesenstrasse 20 9450 Altstätten, Switzerland P + 41 71 757 53 00 investor@coltene.com www.coltene.com

This written statement and oral statements or other statements made, or to be made, by us contain forward-looking statements that do not relate solely to historical or current facts. These forward-looking statements are based on the current plans and expectations of our management and are subject to a number of uncertainties and risks that could significantly affect our current plans and expectations, as well as future results of operations and financial condition. We undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. ----------------------------------------------------------------------------------------------------------------------- End of ad hoc announcement -----------------------------------------------------------------------------------------------------------------------

Language:     English 
Company:      COLTENE Holding AG 
              Feldwiesenstrasse 20 
              9450 Altstätten 
              Switzerland 
ISIN:         CH0025343259 
Valor:        2534325 
Listed:       SIX Swiss Exchange 
EQS News ID:  1210884 
 
End of Announcement EQS Group News Service 
=------------ 

1210884 23-Jun-2021 CET/CEST

 
Image link: 
https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1210884&application_name=news 
 

(END) Dow Jones Newswires

June 23, 2021 01:02 ET (05:02 GMT)

All news about COLTENE HOLDING AG
08/05COLTENE : H1 Profit Jumps to $20 Million on Dental Markets Recovery
MT
08/05EQS-ADHOC : H1 2021: Ongoing Recovery
DJ
08/05Coltene Holding Ag Reports Earnings Results for the Half Year Ended June 30, 2021
CI
06/23COLTENE : Investor Day - positive sales and earnings performance in the first half of the ..
EQ
06/23EQS-ADHOC : Investor Day - positive sales and earnings performance in the first half of th..
DJ
06/23COLTENE Holding AG Provides Earnings Guidance for the First Half and Full Year of Fisca..
CI
05/04COLTENE HOLDING AG : Change in the Group Management
PU
05/04EQS-ADHOC : COLTENE Holding AG: Change in the Group Management
DJ
05/03John Westermeier to Resign from the Group Management of COLTENE At End of June 2021
CI
04/06COLTENE HOLDING AG : Ex-dividend day for
FA
More news
Financials
Sales 2021 273 M 298 M 298 M
Net income 2021 27,5 M 30,0 M 30,0 M
Net Debt 2021 26,3 M 28,7 M 28,7 M
P/E ratio 2021 25,5x
Yield 2021 2,33%
Capitalization 703 M 767 M 767 M
EV / Sales 2021 2,67x
EV / Sales 2022 2,53x
Nbr of Employees 1 189
Free-Float 46,4%
Chart COLTENE HOLDING AG
Duration : Period :
COLTENE Holding AG Technical Analysis Chart | CLTN | CH0025343259 | MarketScreener
Technical analysis trends COLTENE HOLDING AG
Short TermMid-TermLong Term
TrendsBearishBearishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus UNDERPERFORM
Number of Analysts 2
Last Close Price 117,60 CHF
Average target price 115,00 CHF
Spread / Average Target -2,21%
EPS Revisions
Managers and Directors
Martin Schaufelberger Chief Executive Officer
Gerhard Mahrle Chief Financial Officer
Nick Huber Chairman
Martin Schlüter Vice President-Innovation, Research & Development
Stefan Helsing Chief Operating Officer
Sector and Competitors
1st jan.Capi. (M$)
COLTENE HOLDING AG36.74%767
ABBOTT LABORATORIES15.74%224 651
MEDTRONIC PLC5.08%165 656
BECTON, DICKINSON AND COMPANY-1.25%70 962
HOYA CORPORATION21.65%56 316
DEXCOM, INC.53.24%54 815